StonvexLoading…
StonvexStonvexStonvexCore line items from REZI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.47B | $6.76B | $6.24B | $6.37B |
Operating Income | $607.00M | $520.00M | $547.00M | $611.00M |
Net Income | $-527.00M | $116.00M | $210.00M | $283.00M |
EPS (Diluted) | $-3.77 | $0.61 | $1.42 | $1.90 |
Total Assets | $8.43B | $8.20B | $6.64B | $6.39B |
Total Liabilities | $5.52B | $4.89B | $3.90B | $3.86B |
Cash & Equivalents | $661.00M | $692.00M | $636.00M | $326.00M |
Free Cash Flow OCF − CapEx | $-1.25B | $364.00M | $335.00M | $67.00M |
Shares Outstanding | 150.00M | 147.00M | 145.00M | 146.00M |